FOR FURTHER INFORMATION ...

FOR FURTHER INFORMATION ... (The Scientist, Vol:4, #21, pg.12, October 29, 1990) (Copyright, The Scientist, Inc.) ---------- Following is information on how to contact some of the organizations mentioned in the two stories on the Decade of the Brain in this issue. The groups listed here represent only a few of the scores of voluntary health agencies devoted to the study of neurological disorders. National Alliance for the Mentally Ill 2101 Wilson Blvd, Suite 302 Arlington, Va.


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

----------

Following is information on how to contact some of the organizations mentioned in the two stories on the Decade of the Brain in this issue. The groups listed here represent only a few of the scores of voluntary health agencies devoted to the study of neurological disorders.

National Alliance for the Mentally Ill 2101 Wilson Blvd, Suite 302 Arlington, Va. 22201 (703) 524-7600

National Coalition for Research in Neurological and Communicative Disorders Suite 310 3050 K Street, N.W. Washington, D.C. 20007 (202) 293-5453 (202) 293-3204

National Foundation for Brain Research Suite 310 3050 K St., N.W. Washington, D.C. 20007 (202) 293-5453 (202) 293-3204

National Organization for Rare Disorders P.O. Box 8923 New Fairfield, Conn. 06182 (203) 746-6518 (800) 447-6673

National Stroke Association 300 East Hampden Ave. Suite 240 Englewood, Colo. 80110-2622 (303) 762-9922

Parkinson's Disease Foundation William Black Medical Research Building 650 W. 168th St. New York, N.Y. 10032-9982 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide